U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07617194) titled 'Study of AHB-171 in Chronic Hepatitis B Participants' on May 07.
Brief Summary: The goal of this clinical trial is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics of AHB-171 in participants with chronic hepatitis B (CHB). Study advancement to subsequent parts/cohorts will require satisfactory interim reviews of available cumulative safety data by the Safety Review Committees (SRC), using the safety criteria and review procedures described in the protocol.
Study Start Date: July 06
Study Type: INTERVENTIONAL
Condition:
Hepatitis B, Chronic
Intervention:
DRUG: AHB-171
Injection
DRUG: Placebo ma...